Most Recent Articles about NVS
NVS or NVO: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/431571/nvs-or-nvo-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-431571 Jun 19, 2019 - NVS vs. NVO: Which Stock Is the Better Value Option?
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status http://www.zacks.com/stock/news/431105/jazzs-jazz-new-sleep-drug-sunosi-gets-schedule-iv-status?cid=CS-ZC-FT-431105 Jun 18, 2019 - Jazz Pharmaceuticals' (JAZZ) recently approved sleep drug, Sunosi, receives schedule IV designation under controlled substance list from the Drug Enforcement Agency.
Roche's Rozlytrek Gets Approval in Japan for Solid Tumors http://www.zacks.com/stock/news/431013/roches-rozlytrek-gets-approval-in-japan-for-solid-tumors?cid=CS-ZC-FT-431013 Jun 18, 2019 - Roche's (RHHBY) oncology portfolio gets a boost with the approval of Rozlytrek for neurotrophic tyrosine receptor kinase fusion-positive, advanced recurrent solid tumors.

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals